On August 12, 2020, Cosmos Magazine featured insights from AFAR expert Nir Barzilai, MD, on the potential of the drug metformin to extend healthspan. Dr. Barzilai explains how the AFAR-managed Targeting Aging with Metformin (TAME) Trial seeks to provide proof-of-concept that the biology of aging can be targeted, with hopes of receiving an indication for aging from the US Food and Drug Administration.
Dr. Barzilai is AFAR's Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Center Development Award in Aging scholar, and a 2010 Irving S. Wright Award winner, as well as the Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine.
Read the article, “Can ageing really be ‘treated’ or ‘cured’?” here.
